- Home
- Services
- usa massachusetts
- develop new therapies
Show results for
Refine by
Develop New Therapies Services In Usa Massachusetts
8 services found
by:MtoZ Biolabs based in, MASSACHUSETTS (USA)
Immunopeptidomics analysis aims to explore the dynamics and composition of both type I and II immune peptides. Comprehensive characterization of the immunopeptidome aids in developing new therapies for cancer, immune diseases, and infectious diseases. ...
Manufactured by:Mevion Medical Systems based inLittleton, MASSACHUSETTS (USA)
Mevion’s commitment to its customers does not stop at implementation. Mevion looks forward to forming a long-term collaboration to further develop proton therapy as part of a comprehensive customer care ...
Manufactured by:Acorda Therapeutics, Inc. based inPearl River, NEW YORK (USA)
Acorda’s mission is to develop therapies to restore function and improve the lives of people with neurological disorders. Our company is devoted to supporting neurological research, education, and patient assistance through grant and sponsorship programs. We support a broad group of organizations based on the principles of scientifically rigorous research and programs designed to improve ...
by:Pace Analytical based inRoseville, MINNESOTA (USA)
Pace® scientists and project managers are committed to the success of your project. You will have access to experts who can offer advice and guidance based on similar work performed in our gene therapy labs. Our project managers also understand your need for us to be flexible in project scope and timing. ...
by:Pace Analytical based inRoseville, MINNESOTA (USA)
In early-phase gene therapy development, we work with you to determine the most reliable analytical methods to provide the data needed to guide effective development decisions. Next, we deliver a robust assessment of the physicochemical and biophysical characteristics of the therapeutic ...
by:Vor Biopharma based inCambridge, MASSACHUSETTS (USA)
The traditional tumor target paradigm aims to treat hematological malignancies such as acute myeloid leukemia (AML) by focusing on the specificity and potency of therapies that kill cancer cells expressing a target. However, this paradigm is limited by the expression of tumor targets on healthy cells, resulting in on-target toxicity. On-target toxicity has led to the development failure of many ...
by:SOPHiA Genetics based inBoston, MASSACHUSETTS (USA)
Unlocking the potential of precision medicine with Artificial Intelligence – enabled data-driven insights. Advance targeted therapy development by harnessing the power of data and multimodal analytics. Advances in molecular and imaging techniques have resulted in an explosion of data, providing an unprecedented opportunity to identify clinically relevant ...
Manufactured by:Invicro, LLC based inNeedham, MASSACHUSETTS (USA)
Prostate cancer is the most common type of cancer (aside from skin) in American men with 13 out of every 100 being diagnosed with the disease during their lifetime.1,2Prostate-specific membrane antigen (PSMA) is a transmembrane protein that is expressed in high levels in prostate cancer cells. Due to its location on the cell surface, PSMA is a popular target for imaging to identify the presence ...